Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Uterus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT00729586
What this trial is testing

Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial CarcinomaRecurrent Uterine Corpus CarcinomaStage IIIA Uterine Corpus Cancer+5 more
National Cancer Institute (NCI) 73
Not applicableEnded earlyNCT03606486
What this trial is testing

Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer

Who this might be right for
High Grade Ovarian Serous AdenocarcinomaStage III Ovarian Cancer AJCC v8Stage IIIA Ovarian Cancer AJCC v8+7 more
University of Washington 52
Early research (Phase 1)Study completedNCT03586661
What this trial is testing

Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Deleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationEndometrial Adenocarcinoma+8 more
M.D. Anderson Cancer Center 31
Not applicableLooking for participantsNCT04794322
What this trial is testing

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsOvarian Epithelial CarcinomaFallopian Tube Neoplasms+12 more
Massachusetts General Hospital 250
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Active Not RecruitingNCT06129604
What this trial is testing

Pilot Window of Opportunity Trial (POET)

Who this might be right for
Colorectal Carcinoma (CRC)Endometrial Carcinoma (EC)
University of Oklahoma 10
Early research (Phase 1)Not Yet RecruitingNCT07542704
What this trial is testing

Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid TumorsColorectal Cancer (CRC)Non-Small Cell Lung Cancer+3 more
Kumquat Biosciences Inc. 48
Not applicableStudy completedNCT00193804
What this trial is testing

A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix

Who this might be right for
Cancer of Cervix
Tata Memorial Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01026792
What this trial is testing

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+5 more
National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)UnknownNCT00039884
What this trial is testing

Will Radiation/Chemotherapy Treatment of Cervical Cancer Work Better With Medication That May Improve Anemia?

Who this might be right for
AnemiaCervix Neoplasms
Mirhashemi, Ramin, M.D. 64
Testing effectiveness (Phase 2)Study completedNCT00002916
What this trial is testing

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Who this might be right for
Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003065
What this trial is testing

Topotecan and Paclitaxel in Treating Patients With Recurrent or Metastatic Cancer of the Cervix

Who this might be right for
Cervical Cancer
Herbert Irving Comprehensive Cancer Center 25
Not applicableStudy completedNCT02374411
What this trial is testing

Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients

Who this might be right for
Pseudomyxoma PeritoneiAppendiceal NeoplasmsPancreatic Neoplasms+4 more
Edward Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00301964
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Recurrent Endometrial Carcinoma
National Cancer Institute (NCI) 56
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Looking for participantsNCT05150691
What this trial is testing

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Who this might be right for
HER2-positive Advanced Solid Tumor
DualityBio Inc. 796
Early research (Phase 1)Active Not RecruitingNCT03875820
What this trial is testing

Phase I Trial of Defactinib and VS-6766.

Who this might be right for
NSCLCLow Grade Serous Ovarian CancerEndometrioid Carcinoma+1 more
Institute of Cancer Research, United Kingdom 87
Testing effectiveness (Phase 2)Study completedNCT00041093
What this trial is testing

Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer

Who this might be right for
Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedRecurrent Cervical Carcinoma
Gynecologic Oncology Group 27
Next Page